Details of the Drug Formulations

General Information of Drug (ID: DMJIBAW)

Drug Name

Budesonide Drug Info

Synonyms

Bidien; Budenofalk; Budeson; Budesonido; Budesonidum; Budiair; Cortivent; Entocort; Horacort; Inflammide; Micronyl; Miflonide; Preferid; Pulmaxan; Respules; Rhinocort; Spirocort; UDB; Budecort Inhaler; Budesonide Easyhaler; Budesonide MMX; Entocort EC; GionaEasyhaler; Pulmaxan turbohaler; Pulmicort Flexhaler; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Topinasal; Pulmicort turbuhaler; Rhinocort Aqua; Rhinocort Turbuhaler; Rhinocort alpha; Unit dosebudesonide; B 7777; S 1320; Budesonido [INN-Spanish]; Budesonidum [INN-Latin]; Entocort (TN); Entocort EC (TN); MAP-0010; Noex (TN); Pulmicort (TN); Rhinocort (TN); S-1320; Budesonide (JAN/USAN/INN); Budesonide [USAN:INN:BAN:JAN]; Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide; Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-,and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde; (RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde; (S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione; 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione; 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 16alpha-,17alpha-butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione

Indication

Disease Entry	ICD 11	Status	REF
Allergic rhinitis	CA08.0	Approved	[1]
Asthma	CA23	Approved	[2]
Crohn disease	DD70	Approved	[1]
Inflammatory bowel disease	DD72	Approved	[1]
Radiation proctitis		Approved	[1]
Ulcerative colitis	DD71	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 3	[3]

Therapeutic Class

Antiinflammatory Agents

Cross-matching ID

PubChem CID: 5281004
ChEBI ID: CHEBI:3207
CAS Number: 51333-22-3
TTD ID: D0Y7IU
VARIDT ID: DR00323
INTEDE ID: DR0239
ACDINA ID: D00080

Full List of Drug Formulations Containing This Drug

Budesonide 3 mg capsule

Company	Formulation ID	FDA Description
Carilion Materials Management	F02740	Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triethyl citrate; Crospovidone; Polysorbate 80; Silicon dioxide; Dimethicone; Ethylcelluloses; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Teva Pharmaceuticals	F02735	Lactose monohydrate; Acetic acid; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Indigotindisulfonate sodium; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Dimethicone; Ethylcelluloses; Gelatin, unspecified; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Starch, corn
Golden State Medical Supply	F02738	Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Dimethicone; Ethylcellulose, unspecified; Gelatin, unspecified; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Mylan Pharamceuticals	F02739	Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Dimethicone; Ethylcelluloses; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Mylan Pharamceuticals	F02745	Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Dimethicone; Ethylcellulose, unspecified; Gelatin, unspecified; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
Mayne Pharma	F02741	D&c red no. 28; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; D&c red no. 33; Fd&c blue no. 1; Fd&c blue no. 2; Acetyltributyl citrate; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Ethylcellulose (10 mpa.s); Gelatin, unspecified; Hypromellose, unspecified; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Polyethylene glycol, unspecified; Shellac; Starch, corn
Alvogen	F02734	Sodium lauryl sulfate; Cetyl alcohol; Ethyl acrylate; Acetyltributyl citrate; Ammonia; Ferric oxide red; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Water; Polysorbate 80; Ethylcelluloses; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac; Starch, corn
Cadila Healthcare; Zydus Pharmaceuticals	F02733	Sodium lauryl sulfate; Butyl alcohol; Isopropyl alcohol; Acetyltributyl citrate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Water; Polysorbate 80; Alcohol; Dimethicone; Ethylcelluloses; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Shellac
AstraZeneca	F02737	Acetyltributyl citrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Silicon dioxide; Gelatin; Methacrylic acid
Par Pharmaceutical	F02744	Acetyltributyl citrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Ethylcelluloses; Gelatin; Methacrylic acid
Physicians Total Care; Prometheus Laboratories	F02736	Acetyltributyl citrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Colloidal silicon dioxide; Gelatin; Methacrylic acid
Paddock Laboratories,	F02743	Acetyltributyl citrate; Ferric oxide red; Talc; Titanium dioxide; Triethyl citrate; Polysorbate 80; Ethylcelluloses; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a
Appco Pharma; Rising Pharmaceuticals	F02742	Lactose monohydrate; Acetyltributyl citrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Sodium hydroxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ethylcelluloses; Gelatin; Methacrylic acid; Shellac; Starch, corn
------------------------------------------------------------------------------------


⏷ Show the Full List of 13 Formulation(s)

Budesonide 9 mg tablet

Company	Formulation ID	FDA Description
Santarus	F02746	Stearic acid; Lactose, unspecified form; Magnesium stearate; Talc; Titanium dioxide; Triethyl citrate; Hydroxypropyl cellulose (80000 mw); Lecithin, soybean; Silicon dioxide; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Microcrystalline cellulose
------------------------------------------------------------------------------------

References

1	Budesonide FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7434).
3	Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia